Product Information
BROMOCRIPTINE 2.5 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $1.6095 per EA under NDC 70954097810. Its NADAC has been published 60 times since Aug 13, 2025.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954097810
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BROMOCRIPTINE MESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA017962FDA Approved
Before 1982
TE Code
AB
On Market Since
6/15/2025
Pharmacological Classes
Price Statistics
The NADAC for BROMOCRIPTINE 2.5 MG TABLET has been published 60 times since Aug 13, 2025, and over the history we have for it it has risen 2.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6095 per EA |
|---|---|
| All-time high | $1.7958 (Dec 10, 2025) |
| All-time low | $1.5675 (Aug 13, 2025) |
| 52-week high | $1.7958 |
| 52-week low | $1.6058 |
| Median price | $1.7106 |
| Average price | $1.7008 |
| Largest weekly change | +7.2% (Aug 20, 2025) |
| Weeks tracked | 60 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bromocriptine Mesylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Ergot Derivative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BROMOCRIPTINE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BROMOCRIPTINE 2.5 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $1.6095 per EA (NDC 70954097810), effective Sep 30, 2026.
How has the price of BROMOCRIPTINE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BROMOCRIPTINE 2.5 MG TABLET has risen 2.7%. It has been tracked across 60 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for BROMOCRIPTINE 2.5 MG TABLET?
Since Aug 13, 2025, the NADAC for BROMOCRIPTINE 2.5 MG TABLET has ranged from a low of $1.5675 (Aug 13, 2025) to a high of $1.7958 (Dec 10, 2025), with a median of $1.7106 per EA.
Are there cheaper alternatives to BROMOCRIPTINE 2.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BROMOCRIPTINE 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BROMOCRIPTINE 2.5 MG TABLET?
BROMOCRIPTINE 2.5 MG TABLET (NDC 70954097810) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.